Empirical Asset Management’s AGF US Market Neutral Anti-Beta Fund BTAL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$144K Buy
+12,897
New +$157K 0.03% 426
2024
Q3
Sell
-51,740
Closed -$1.02M 314
2024
Q2
$1.02M Sell
51,740
-19,461
-27% -$369K 0.38% 65
2024
Q1
$1.28M Buy
71,201
+4,739
+7% +$86K 0.62% 38
2023
Q4
$1.13M Sell
66,462
-2,642
-4% -$52.5K 0.92% 26
2023
Q3
$1.37M Buy
69,104
+52
+0.1% +$985 1.2% 20
2023
Q2
$1.3M Buy
69,052
+2,904
+4% +$58.6K 1.15% 22
2023
Q1
$1.35M Buy
66,148
+15,716
+31% +$316K 1.29% 22
2022
Q4
$1.07M Sell
50,432
-3,118
-6% -$64.6K 1.13% 18
2022
Q3
$1.09M Buy
53,550
+1,992
+4% +$39.7K 1.19% 19
2022
Q2
$1.12M Buy
51,558
+8,316
+19% +$168K 1.18% 20
2022
Q1
$793K Buy
43,242
+6,999
+19% +$129K 0.75% 45
2021
Q4
$644K Buy
+36,243
New +$616K 0.62% 55

Other funds holding BTAL

Empirical Asset Management's BTAL Position: Q2 2026 in Review

Empirical Asset Management opened a new position in AGF US Market Neutral Anti-Beta Fund (BTAL) in Q2 2026: 12,897 shares worth $144K. The stake represents 0.03% of the portfolio and ranks #426 among its holdings. This is a return to the name: Empirical Asset Management previously reported a position in BTAL as recently as Q2 2024.

Empirical Asset Management first reported a position in BTAL in Q4 2021 and has held it in 12 quarters since. The position peaked at $1.37M in Q3 2023. 93 funds tracked by Wall St. Rank hold BTAL as of Q2 2026.

  • Empirical Asset Management held 12,897 shares of AGF US Market Neutral Anti-Beta Fund worth $144K as of Q2 2026.
  • AGF US Market Neutral Anti-Beta Fund was a new Empirical Asset Management position in Q2 2026.
  • AGF US Market Neutral Anti-Beta Fund made up 0.03% of Empirical Asset Management's portfolio in Q2 2026, its #426 holding.
  • Empirical Asset Management first reported a position in AGF US Market Neutral Anti-Beta Fund in Q4 2021 and has held it in 12 quarters since.
  • Empirical Asset Management's AGF US Market Neutral Anti-Beta Fund position peaked at $1.37M in Q3 2023.
  • 93 funds tracked by Wall St. Rank held AGF US Market Neutral Anti-Beta Fund as of Q2 2026.

Based on Empirical Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.